Monday, Nov. 23, 2020 | 2 a.m.
Damage wreaked on the Strip doesn’t affect just casino workers. I’m a limo driver, and the spring shutdowns left me without a job. Reduced demand means I’m still not working, and the many additional casino layoffs that loom make me fearful that I won’t be called back anytime soon. Like nearly everyone in the service industry, I’m spending less money, and that belt-tightening is affecting all types of businesses and jobs nationwide.
That’s why it’s vital that new treatments for COVID-19 are developed quickly, so people feel more confident that if they catch the coronavirus, doctors have the tools to help them overcome it. Even more important are vaccines, so everyone can gain immunity and we can all get back to living — to dining out, traveling, gathering for family holidays and traditions.
Biopharmaceutical development is critical now for every American, like it’s always been for those suffering from serious diseases, who keep their fingers crossed that a cure will come in time.
As the world leader in biopharmaceutical innovation, the U.S. must lead and accelerate research into COVID-19 treatments and cures. This is why I voted and why I expect our newly elected leaders to fulfill their campaign promises and support innovation. Nobody wants a sicker Nevada or a longer pandemic, so we must support scientists and researchers as they work tirelessly on a vaccine.